SYNTHON HISPANIA SL

Location

Founded

1998-07-31

Risk Signals

70 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Medicinal Chemicals and Botanical Products), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about SYNTHON HISPANIA SL

Live alerts from global media, monitored by Business Radar

Santiago Court of Appeals rejected Synthon Chile claim and confirms partial delivery of clinical studies - | Legal News

2025-02-01 (doe.cl)

Santiago Court of Appeals rejected Synthon Chile claim and confirms partial delivery of clinical studies - | Legal News

The ISP ordered to targe any antecedent that says relationship or contains data that account for the formula of the products consulted, and of any personal data of context and sensitive data that they may contain.

Read more
Regulatory approval in Europe granted for Synthon's Glatiramer Acetate

(biospectrumasia.com)

Regulatory approval in Europe granted for Synthon's Glatiramer Acetate

Synthon received regulatory clearance in all 27 EU/EEA member states involved in the procedures

Read more

Never miss a headline about SYNTHON HISPANIA SL

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages